A

Alexion

Global biopharmaceuticals focusing on rare diseases

Head of Medical Affairs - Rare Bone & Endocrine Disorders, Rare Tumours

Biology & BiotechConfirmed live in the last 24 hours
Full-timeTokyo, JapanNo salary listed

About the Job

Requirements

  • Must have an MD, PhD, or PharmD-level degree or equivalent.
  • Must have 5 or more years of experience in a Global or International Medical Affairs function.
  • Must have excellent written and verbal communication skills.
  • Must have experience and ability to work in a matrixed cross-functional environment, both internally and remotely.
  • Must have interpersonal skills and demonstrated ability to drive results as an effective team member and project leader.
  • Must have the ability to manage budgets and resources.
  • Must have strong business acumen.
  • Must have the ability to build effective partnerships between headquarters and affiliates.
  • Must be flexible and able to adapt to changing conditions.
  • Must have problem-solving, organizational, and negotiating skills.
  • Must demonstrate energy and enthusiasm, a positive approach to challenges, and a strong sense of ethics and responsibility.
  • Must be willing to travel up to 25%.

Responsibilities

  • Provide strategic leadership to the assigned therapeutic area portfolio, including in-line and pipeline assets, using deep scientific and medical expertise and a strong understanding of disease biology, the patient journey, and the treatment landscape.
  • Develop and implement strategic plans for multiple compounds and indications in a strongly matrixed environment with effective cross-functional collaboration.
  • Collaborate with Global, Regional, and Japan Medical Affairs stakeholders to maximize patient outcomes by setting and continuously advancing the evidence-based medical standard of care.
  • Lead and develop Medical Leads, MSL leadership, and the broader matrix medical organization as applicable.
  • Develop and implement local medical strategies and strategically aligned tactical plans, and oversee their execution across assets, indications, lifecycle stages, and evidence-generation priorities in the Rare Bone & Endocrine Disorders and Rare Tumours area.
  • Ensure solid scientific medical planning and execution to positively impact patient outcomes in the responsible disease area.
  • Ensure the quality of medical strategies in Japan and alignment with corporate and brand strategies.
  • Be accountable for day-to-day operational execution and the quality and strategic alignment of medical activities to build local evidence and trust with external experts, healthcare professionals, patient communities, and internal stakeholders.
  • Represent Japan Medical Affairs for the responsible therapeutic area at relevant Global and Japan Product Teams.
  • Lead the organization to ensure effective and efficient operations through continuous improvement, strategic direction development, business and resource planning, budget management, and leadership of medical organizations.
  • Ensure organizational strategy aligns with global and regional medical strategies and enterprise priorities for the relevant therapeutic area.
  • Be responsible for related human-resources activities, including talent development, evaluation, and recruitment.
  • Partner cross-functionally with Commercial, Market Access, Clinical Development, Regulatory, Safety, and other relevant functions.
  • As a member of the Medical Affairs Leadership Team, contribute to the success of the entire medical department across functions and roles, embedding corporate values, culture, and vision across the broader medical organization.
  • Ensure the medical organization is a trusted cross-functional partner to Commercial and other relevant functions through internal communication, participation in the JLC, cross-functional engagement, and execution of medical activities.
  • Escalate key issues and present recommendations or solutions to the Medical Leadership Team and/or JLC as necessary.

Desired Qualifications

  • Scientific and technical acumen in the relevant therapeutic area.
  • Understanding of evidence generation, health economics and outcomes research, and the access and reimbursement environment.
  • Understanding of global and local healthcare environments, stakeholder needs, and access considerations.

About the Company

Alexion

Global biopharmaceuticals focusing on rare diseases

Alexion, now the rare disease group within AstraZeneca, develops and sells therapies for rare and ultra-rare diseases by targeting the complement immune system. Its drugs, such as Soliris and Ultomiris, inhibit the C5 component to slow or stop disease processes, while Strensiq and Kanuma address specific metabolic disorders. It differentiates itself through a deep focus on complement biology, pursuing first- or best-in-class therapies, and using a strategy that blends internal R&D with acquisitions to expand its pipeline. Its goal is to improve outcomes for patients with rare diseases and bring these therapies to a broader international market using AstraZeneca’s scale and capabilities.

Company size
5,001-10,000
Company stage
IPO
Headquarters
Boston, MA
Founded
1992

Recently Posted Jobs

Explore more opportunities at Alexion

See more jobs